NEW YORK (GenomeWeb) – Caribou Biosciences, a CRISPR platform technology firm, has completed a $30 million Series B financing round.

New investors Anterra Capital, Heritage Group, Maverick Capital Ventures, and Pontifax AgTech joined existing investors in the round, including F-Prime Capital Partners, Novartis, Mission Bay Capital, and 5 Prime Ventures.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.